Hemenway Trust CO LLC Alnylam Pharmaceuticals, Inc. Transaction History

Hemenway Trust CO LLC

  • $1.19 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2018

Apr 24, 2018
SELL
$115.92 - $148.54 $253,053 - $324,262
-2,183 Closed
0 $0
Q4 2017

Feb 02, 2018
SELL
$114.49 - $139.98 $70,411 - $86,087
-615 Reduced 21.98%
2,183 $277,000
Q3 2017

Oct 26, 2017
BUY
$72.53 - $118.27 $202,938 - $330,919
2,798
2,798 $329,000

Others Institutions Holding ALNY

# of Institutions
644
Shares Held
109M
Call Options Held
1.28M
Put Options Held
1.21M
View Full List

About ALNYLAM PHARMACEUTICALS, INC.

ALNY Quotes by TradingView
  • Ticker ALNY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 123,028,000
  • Market Cap $30.3B
  • Description
  • Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...
More about ALNY
Track This Portfolio

Track Hemenway Trust CO LLC Portfolio

Follow Hemenway Trust CO LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hemenway Trust CO LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hemenway Trust CO LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email